ArticleOncotarget2017

Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.

Yong Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.